Updated on 2025/07/02

All information, except for affiliations, is reprinted from the information registered on researchmap.

写真a

 
Kenji Matsumoto
 
Organization
School of Medicine Medical Course Lecturer
Title
Lecturer
Profile
筑波大学医学専門学群、東京大学大学院医科学研究科卒業。
血液内科医として研鑚を積み、2016年からは横浜市立大学にて臨床および基礎研究に従事している。
External link

Degree

  • 博士(医学) ( 東京大学 )

Research Interests

  • 血液腫瘍学

Research Areas

  • Life Science / Hematology and medical oncology

Papers

  • Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective Study Reviewed

    Takayoshi Tachibana, Taiki Andou, Masatsugu Tanaka, Satomi Ito, Takuya Miyazaki, Yoshimi Ishii, Eriko Ogusa, Hideyuki Koharazawa, Hiroyuki Takahashi, Kenji Motohashi, Jun Aoki, Yuki Nakajima, Kenji Matsumoto, Maki Hagihara, Chizuko Hashimoto, Jun Taguchi, Katsumichi Fujimaki, Hiroyuki Fujita, Shin Fujisawa, Heiwa Kanamori, Hideaki Nakajima, Yokohama Cooperative Study Group for Hematology (YACHT)

    Clinical Lymphoma, Myeloma and Leukemia   18 ( 6 )   415 - 421   2018.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier Inc.  

    DOI: 10.1016/j.clml.2018.03.009

    Scopus

    PubMed

    researchmap

  • Anemia associated with worse outcome in diffuse large B-cell lymphoma patients: a single-center retrospective study. Reviewed International journal

    Matsumoto K, Fujisawa S, Ando T, Koyama M, Koyama S, Ishii Y, Numata A, Yamamoto W, Motohashi K, Hagihara M, Nakajima H

    Turkish journal of haematology : official journal of Turkish Society of Haematology   35 ( 3 )   181 - 184   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Objective: Useful prognostic biomarkers for diffuse large B-cell lymphoma (DLBCL) patients have been reported. To determine the prognostic value of hemoglobin (Hb) level in DLBCL patients, we performed a retrospective study. Materials and Methods: We evaluated disease outcome, progression-free survival (PFS), overall survival as the endpoint, and clinical and laboratory factors affecting the outcome of 185 DLBCL patients who had received rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy during 2004-2014. Results: The study group included 121 men and 64 women with a median age of 66 years minimum-maximum: 21-83 years. In univariate analysis, factors independently associated with worse PFS were Eastern Cooperative Oncology Group performance status ≥2, Ann Arbor stage III or IV, anemia with Hb levels of <10 g/dL, and serum albumin of <3.5 g/dL. In multivariate analysis, anemia with Hb levels of <10 g/dL and Ann Arbor stage III or IV were found to be international index-independent prognostic factors (hazard ratio: 2.4; p=0.04). Conclusion: Anemia is an independent prognostic marker of poor outcome in DLBCL patients. Hb can be an easily available prognostic marker for risk stratification in these patients.

    DOI: 10.4274/tjh.2017.0437

    PubMed

    researchmap

  • Outcome and prognostic factors among patients who underwent a second transplantation for disease relapse post the first allogeneic cell transplantation Reviewed

    Takayoshi Tachibana, Kenji Matsumoto, Masatsugu Tanaka, Maki Hagihara, Kenji Motohashi, Wataru Yamamoto, Eriko Ogusa, Satoshi Koyama, Ayumi Numata, Naoto Tomita, Jun Taguchi, Shin Fujisawa, Heiwa Kanamori, Hideaki Nakajima

    LEUKEMIA & LYMPHOMA   58 ( 6 )   1403 - 1411   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1080/10428194.2016.1243678

    Web of Science

    PubMed

    researchmap

  • Body mass index is a prognostic factor in adult patients with acute myeloid leukemia Reviewed

    Taiki Ando, Etsuko Yamazaki, Eriko Ogusa, Yoshimi Ishii, Wataru Yamamoto, Kenji Motohashi, Takayoshi Tachibana, Maki Hagihara, Kenji Matsumoto, Masatsugu Tanaka, Chizuko Hashimoto, Hideyuki Koharazawa, Katsumichi Fujimaki, Jun Taguchi, Hiroyuki Fujita, Heiwa Kanamori, Shin Fujisawa, Hideaki Nakajima

    INTERNATIONAL JOURNAL OF HEMATOLOGY   105 ( 5 )   623 - 630   2017.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-017-2183-7

    Web of Science

    PubMed

    researchmap

  • Hyper-recovery of platelets after induction therapy is a predictor of relapse-free survival in acute myeloid leukemia Reviewed

    Etsuko Yamazaki, Heiwa Kanamori, Megumi Itabashi, Eriko Ogusa, Ayumi Numata, Wataru Yamamoto, Satomi Ito, Takayoshi Tachibana, Maki Hagihara, Kenji Matsumoto, Hideyuki Koharazawa, Jun Taguchi, Naoto Tomita, Katsumichi Fujimaki, Hiroyuki Fujita, Shin Fujisawa, Koji Ogawa, Yoshiaki Ishigatsubo

    LEUKEMIA & LYMPHOMA   58 ( 1 )   104 - 109   2017

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1080/10428194.2016.1190969

    Web of Science

    PubMed

    researchmap

  • Favorable prognosis in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia patients following hematopoietic stem cell transplantation Reviewed

    Ayumi Numata, Shin Fujisawa, Megumi Itabashi, Yoshimi Ishii, Wataru Yamamoto, Kenji Motohashi, Kenji Matsumoto, Maki Hagihara, Hideaki Nakajima

    CLINICAL TRANSPLANTATION   30 ( 5 )   485 - 486   2016.5

     More details

  • Prognostic value of pretransplant serum C-reactive protein in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation Reviewed

    Wataru Yamamoto, Eriko Fujii, Kenji Matsumoto, Eri Yamamoto, Jun Aoki, Masatsugu Tanaka, Yoshiaki Ishigatsubo, Heiwa Kanamori

    INTERNATIONAL JOURNAL OF HEMATOLOGY   103 ( 4 )   444 - 452   2016.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-016-1941-2

    Web of Science

    PubMed

    researchmap

  • Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation Reviewed

    Ayumi Numata, Ryoko Kajiyama, Megumi Itabashi, Yoshimi Ishii, Wataru Yamamoto, Kenji Motohashi, Kenji Matsumoto, Maki Hagihara, Yoshiaki Ishigatsubo, Shin Fujisawa

    LEUKEMIA & LYMPHOMA   57 ( 1 )   201 - 202   2016.1

  • Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient Reviewed

    Yoshimi Ishii, Megumi Itabashi, Ayumi Numata, Wataru Yamamoto, Kenji Motohashi, Maki Hagihara, Kenji Matsumoto, Shin Fujisawa

    INTERNAL MEDICINE   55 ( 6 )   673 - 675   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.55.5644

    Web of Science

    PubMed

    researchmap

  • Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis Reviewed

    Wataru Yamamoto, Taiki Andou, Megumi Itabashi, Satoshi Koyama, Yoshimi Ishii, Ayumi Numata, Kenji Motohashi, Maki Hagihara, Kenji Matsumoto, Shin Fujisawa

    INTERNAL MEDICINE   55 ( 13 )   1721 - 1727   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.55.6094

    Web of Science

    PubMed

    researchmap

  • Retrospective Study of Incidence and Prognostic Significance of Eosinophilia after Allogeneic Hematopoietic Stem Cell Transplantation: Influence of Corticosteroid Therapy Reviewed

    Wataru Yamamoto, Eriko Ogusa, Kenji Matsumoto, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori

    TURKISH JOURNAL OF HEMATOLOGY   33 ( 3 )   196 - 201   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.4274/tjh.2015.0047

    Web of Science

    PubMed

    researchmap

  • Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy Reviewed

    Kazuho Miyashita, Naoto Tomita, Masataka Taguri, Taisei Suzuki, Yasufumi Ishiyama, Yoshimi Ishii, Yuki Nakajima, Ayumi Numata, Yukako Hattori, Wataru Yamamoto, Takuya Miyazaki, Takayoshi Tachibana, Hirotaka Takasaki, Kenji Matsumoto, Chizuko Hashimoto, Sachiya Takemura, Etsuko Yamazaki, Katsumichi Fujimaki, Rika Sakai, Shigeki Motomura, Yoshiaki Ishigatsubo

    LEUKEMIA RESEARCH   39 ( 11 )   1187 - 1191   2015.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.leukres.2015.08.016

    Web of Science

    PubMed

    researchmap

  • [Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy]. Reviewed

    Koharazawa H, Watanabe R, Hattori Y, Numata A, Kawasaki R, Kuwabara H, Hagihara M, Matsumoto K, Tanaka M, Hashimoto C, Takemura S, Yamazaki E, Fujimaki K, Taguchi J, Tomita N, Fujita H, Sakai R, Harano H, Ishigatsubo Y, Fujisawa S

    [Rinsho ketsueki] The Japanese journal of clinical hematology   56 ( 4 )   392 - 399   2015.4

  • Successful Engraftment and Durable Graft-versus-host Disease Control with Haploidentical Peripheral Blood and a Short-term Conditioning Regimen for Primary Graft Failure Reviewed

    Takayoshi Tachibana, Eri Yamamoto, Rika Kawasaki, Hideyuki Koharazawa, Daisuke Ishibashi, Yuki Nakajima, Masatsugu Tanaka, Kenji Matsumoto, Yoshiaki Ishigatsubo, Shin Fujisawa

    INTERNAL MEDICINE   54 ( 21 )   2749 - 2752   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.54.4809

    Web of Science

    PubMed

    researchmap

  • Successful azacitidine treatment with increase of regulatory T cells for relapsed acute myeloid leukemia after allogeneic stem cell transplant Reviewed

    Wataru Yamamoto, Takayoshi Tachibana, Eriko Ogusa, Kenji Matsumoto, Atsuo Maruta, Yoshiaki Ishigatsubo, Heiwa Kanamori

    LEUKEMIA & LYMPHOMA   54 ( 9 )   2079 - 2080   2013.9

  • Upfront Autologous Stem Cell Transplantation for Untreated High-Risk Diffuse Large B-Cell Lymphoma in Patients Up to 60 Years of Age Reviewed

    Hirotaka Takasaki, Chizuko Hashimoto, Atsuko Fujita, Kenji Matsumoto, Jun Taguchi, Hideyuki Kuwabara, Etsuko Yamazaki, Hideyuki Koharazawa, Hiroyuki Fujita, Shin Fujisawa, Yoshimi Ishii, Wataru Yamamoto, Shigeki Motomura, Naoto Tomita, Yoshiaki Ishigatsubo, Rika Sakai

    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA   13 ( 4 )   404 - 409   2013.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.clml.2013.03.003

    Web of Science

    PubMed

    researchmap

  • Clinical significance of minimal residual disease detected by multidimensional flow cytometry: Serial monitoring after allogeneic stem cell transplantation for acute leukemia Reviewed

    Takuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, Takeshi Hosoyama, Reina Watanabe, Takayoshi Tachibana, Atsuko Fujita, Kenji Matsumoto, Masatsugu Tanaka, Hideyuki Koharazawa, Jun Taguchi, Naoto Tomita, Rika Sakai, Shin Fujisawa, Heiwa Kanamori, Yoshiaki Ishigatsubo

    LEUKEMIA RESEARCH   36 ( 8 )   998 - 1003   2012.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.leukres.2012.04.005

    Web of Science

    PubMed

    researchmap

  • Retrospective study of the utility of FLIPI/FLIPI-2 for follicular lymphoma patients treated with R-CHOP. Reviewed

    Numata A, Tomita N, Fujimaki K, Tanaka M, Hashimoto C, Oshima R, Matsumoto K, Matsuura S, Yamamoto W, Motomura S, Ishigatsubo Y

    Journal of clinical and experimental hematopathology : JCEH   52 ( 1 )   77 - 79   2012

     More details

    Language:English   Publisher:The Japanese Society for Lymphoreticular Tissue Research  

    DOI: 10.3960/jslrt.52.77

    PubMed

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2013247921

  • Primary Hepatic Peripheral T-Cell Lymphoma Treated with Corticosteroid Reviewed

    Kazuho Miyashita, Naoto Tomita, Hisashi Oshiro, Chihiro Matsumoto, Yuki Nakajima, Satomi Ito, Kenji Matsumoto, Hiroyuki Fujita, Yoshiaki Ishigatsubo

    INTERNAL MEDICINE   50 ( 6 )   617 - 620   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.50.4686

    Web of Science

    PubMed

    researchmap

  • Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions Reviewed

    Takuya Miyazaki, Yohei Kirino, Mitsuhiro Takeno, Maasa Hama, Ayumi Ushihama, Reina Watanabe, Kaoru Takase, Takayoshi Tachibana, Kenji Matsumoto, Masatsugu Tanaka, Satoshi Yamaji, Haruko Ideguchi, Naoto Tomita, Hiroyuki Fujita, Shigeru Ohno, Atsuhisa Ueda, Yoshiaki Ishigatsubo

    INTERNATIONAL JOURNAL OF HEMATOLOGY   91 ( 2 )   229 - 237   2010.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-010-0495-y

    Web of Science

    PubMed

    researchmap

  • Stepwise Development of Hematopoietic Stem Cells from Embryonic Stem Cells Reviewed

    Kenji Matsumoto, Takayuki Isagawa, Toshinobu Nishimura, Takunori Ogaeri, Koji Eto, Satsuki Miyazaki, Jun-ichi Miyazaki, Hiroyuki Aburatani, Hiromitsu Nakauchi, Hideo Ema

    PLOS ONE   4 ( 3 )   e4820   2009.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0004820

    Web of Science

    PubMed

    researchmap

▼display all

MISC

▼display all